4D-150 Phase III wet AMD trials fully enrolled; data due next year
4D-150 Phase III trials in wet AMD are fully enrolled. Major data readouts are expected next year for the therapy aimed at reducing treatment burden and preserving vision.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.